Opinion
For NSCLC, neoadjuvant, adjuvant, or both?
- Author:
- H. Jack West, MD
- Julia Rotow, MD
I think it’s a great place for shared decision-making because if a patient hears about that and decides they’re not interested, I’ll be fine with...
Opinion
Did an unfair system help ADAURA win on overall survival?
- Author:
- H. Jack West, MD
Although I strongly suspect that the overall survival difference would have been significant without the disparity in access to osimertinib in the...
Opinion
When practice-changing results don’t change practice
- Author:
- H. Jack West, MD
But among many of my colleagues who favor adjuvant over neoadjuvant therapy, it isn’t necessarily the fine points of the data that present the...
Opinion
Local therapies show promise for metastatic lung cancer
- Author:
- H. Jack West, MD
Local therapy for colorectal cancer with limited liver-only metastases is now established as a path to potentially excellent long-term survival....
Article
Advances in Non–Small Cell Lung Cancer From SITC 2022
- Author:
- H. Jack West, MD
The role of gene mutations in outcomes and treatment resistance, a novel LAG-3 inhibitor, and the case for neoadjuvant therapy are among the NSCLC...
Opinion
Discontinuing immunotherapy: Is the infusion bag half empty or half full?
- Author:
- H. Jack West, MD
Clinical trials of immunotherapy or chemoimmunotherapy have generally terminated treatment in nonprogressing patients after 2 years.
Article
Highlights in Advanced Non–Small Cell Lung Cancer From ESMO 2022
- Author:
- H. Jack West, MD
Highlights in NSCLC from ESMO 2022 include sotorasib in KRAS G12C mutated disease, 5-year data on pembrolizumab, and novel treatment...
Article
Key Data on Early Non–Small Cell Lung Cancer From ESMO 2022
- Author:
- H. Jack West, MD
Osimertinib dosing periods, the use of ctDNA to predict recurrence, and the role of air pollution in promoting lung cancer are among...
Opinion
Is a progression-free survival benefit alone really worth $10,000 a month?
- Author:
- H. Jack West, MD
We consider the physician-patient relationship to be autonomous, but we ignore the fact that both are deciding on treatments that are funded by...
Opinion
Five reasons why medical meetings will never be the same
- Author:
- H. Jack West, MD
Dr. Jack West argues that we shouldn’t necessarily rush to return to the previous status quo of live, in-person...